Patents Assigned to Coeurative, Inc.
  • Methods of using nitric oxide donor compounds for treatment of COVID-19 and other infectious diseases
    Patent number: 11779560
    Abstract: The present invention provides novel methods of using nitric oxide donor compounds for treating infectious diseases, for example, COVID-19.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: October 10, 2023
    Assignee: Coeurative, Inc.
    Inventor: John Frederick Schmedtje, Jr.
  • METHODS OF USING NITRIC OXIDE DONOR COMPOUNDS FOR TREATMENT OF COVID-19 AND OTHER INFECTIOUS DISEASES
    Publication number: 20210346335
    Abstract: The present invention provides novel methods of using nitric oxide donor compounds for treating infectious diseases, for example, COVID-19.
    Type: Application
    Filed: March 24, 2021
    Publication date: November 11, 2021
    Applicant: COEURATIVE, INC.
    Inventor: John F. Schmedtje, JR.
  • Compounds useful for treating cardiovascular diseases
    Patent number: 10913748
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof and methods of using the same for treating cardiovascular diseases.
    Type: Grant
    Filed: October 12, 2019
    Date of Patent: February 9, 2021
    Assignee: Coeurative, Inc.
    Inventor: John Frederick Schmedtje, Jr.
  • NOVEL COMPOUNDS USEFUL FOR TREATING CARDIOVASCULAR DISEASES
    Publication number: 20200181161
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof and methods of using the same for treating cardiovascular diseases.
    Type: Application
    Filed: October 12, 2019
    Publication date: June 11, 2020
    Applicant: Coeurative, Inc.
    Inventor: John Frederick Schmedtje, JR.